Complexation of intracellular cyanide by hydroxocobalamin using a human cellular model

Human & Experimental Toxicology

Volumn 15, Issue 1, 1996, Pages 19-25

  Astier, Alain ^a   Baud, Frederic J ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b HÔPITAL FERNAND WIDAL   (France)

Author keywords

antidote; cellular model; cyanide; cyanocobala min; hydroxocobalamin

Indexed keywords

ANTIDOTE; COBALT DERIVATIVE; HYDROXOCOBALAMIN;

ARTICLE; CELL LINE; COMPLEX FORMATION; CONTROLLED STUDY; CULTURE MEDIUM; CYANIDE POISONING; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TOXICOLOGY;

ANTIDOTES; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYANIDES; FIBROBLASTS; HEMATINICS; HUMANS; HYDROXOCOBALAMIN; SKIN; VITAMIN B 12;

EID: 0030054119     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/096032719601500104     Document Type: Article

References (28)

1. Ballantyne B. Toxicology of cyanides, in Clinical and Experimental Toxicology of Cyanides, eds. Ballantyne B & Marrs TC, pp. 41-126, Bristol: Wrigth, 1987.
2. Marrs TC The choice of cyanide antidote, in Clinical and Experimental Toxicology of Cyanides, eds. Ballantyne B & Marrs TC, pp. 343-401, Bristol: Wrigth, 1987.
3. Chen KK & Rose CL Nitrite and thiosulfate therapy in cyanide poisoning. JAMA 1952; 149: 113-119.
4. Burrows GE & Way JL Cyanide intoxication in sheep: efficacy of sodium nitrite, sodium thiosulfate and cobaltous chloride. American Journal of Veterinary Research 1979; 40: 613-617.
5. Frankenberg L. Enzyme therapy in cyanide poisoning: Effect of rhodanase and sulfur compounds. Archive of Toxicology 1975; 45: 315-323.
6. Mushett CW, Kelley KL, Boxer GE & Rickards JC Antidotal efficacy of vitamine B12 a (hydroxocobalamin) in experimental cyanide poisoning. Proceeding of the Society of Experimental & Biological Medicine 1952; 81: 234-237.
7. Paulet G. Etat actuel du traitement de I'intoxication cyanhydrique. Archives des Maladies Professionnelles 1964; 45: 182-192.
8. Lovatt Evans C. Cobalt compounds as antidote for hydrocyanic acid. British Journal of Pharmacology 1964; 23: 455-475.
9. Yacoub M., Faure J., Morena H., Vincent M. & Faure H. L'intoxication cyanhydrique aigue. Données actuelles sur le métabolisme du cyanure et le traitement par hydroxocobalamin. Journal Europeen de Toxicology 1974; 7: 22-29.
10. Pontal PG, Bismuth C., Garnier R. & Pronckzuc de Garbino J, Therapeutic attitude in cyanide poisoning: retrospective study of 24 non-lethal cases., Veterinary and Human Toxicology 1982; 24: 90-94.
11. Riou B., Lecarpentier Y., Toffis V., Barriot P., Baud FJ, Astier A. In vitro demonstration of the efficacy of hydroxocobalamin in cyanide poisoning. Journal of Neurosurgical Anesthesiology 1990; 2: 296-304.
12. Way JL Cyanide intoxication and its mechamism of antagonism. Annual Review of Pharmacology 1984; 24: 451-484.
13. Carlson AJ On the action of cyanide on the heart. American Journal of Physiology, 1907; 9: 223-232.
14. Lanoue KF & Schoolwerth. Metabolic transport in mitochondria. Annual Review of Biochemistry 1979; 48: 871-822.
15. Stoscheck CM Quantitation of proteins, in Methods in enzymology vol. 182: Guide to proteins purification, ed. Deutscher MP, pp. 62-63, San Diego: Academic Press, 1990.
16. Baskin SI, Wilkerson G., Alexander K. & Blitstein AG Cardiac effects of cyanide, in Clinical and Experimental Toxicology of Cyanides, eds. Ballantyne B & Marrs TC, pp. 138-155, Bristol: Wrigth, 1987.
17. McMillan DE & Svoboda AC The role of erythrocytes in cyanide detoxification. Journal of Pharmacology and Experimental Therapeutic 1982; 221: 37-41
18. Duggard PH The absorption of cyanide through human skin in vitro from solutions of sodium cyanide and gaseous HCN, in Clinical and Experimental Toxicology of Cyanides, eds. Ballantyne B & Marrs TC, pp. 127-137, Bristol: Wrigth, 1987.
19. Ballantyne B. Blood brain and cerebrospinal fluid cyanide concentrations in experimental acute poisoning. Journal of Forensic Sciences 1975; 15: 51-56.
20. Gourdin MF, Vasconcelos AW, Tabilio A., Divine M., Farcet JP & Reyes F. Human mononuclear phagocyte dufferentiation: a study of the U-937 cell line by ultrastructural cytochemisty and surface antigen analysis. British Journal of Haematology 1985; 61: 281-291.
21. Chen Lan B. Mitochondrial membrane potential in living cells. Annual Review in Cell Biology 1988; 4: 155-181.
22. Hall CA, Begley JA & Green-Colligan PD. The availability of hydroxocobalamin to cells. Blood 1984; 63 335-341.
23. Baud FJ, Barriot P., Toffis V. et al. Elevated blood cyanide concentrations in victims of smoke inhalation. New England Journal of Medicine. 1991; 325: 1761-1766.
24. A. Astier & FJ Baud. Simultaneous determination of hydroxocobalamin and its cyanide complex cyanocobalamin in human plasma by high performance liquid chromatography. Application to pharmacokinetic studies after high dose hydroxocobalamin as antidote of severe cyanide poisoning. Journal of Chromatography Biomedical Applications, 1995; 667: 129-135.
25. De la Coussaye JE, Houeto P., Sandouk P., Levillain P., Sassine A. & Riou B. Pharmacokinetics of hydroxocobalamin in dogs. Journal of Neurosurgical Anesthesiology 1994; 2: 111-115.
26. Worm-Petersen & Poulsen E. Transport of vitamin B12 from blood to cerebrospinal fluid. Biochemical Pharmacology 1961; 8: 323-324.
27. Fenton WA & Rosenberg LE Mitochondrial metabolism of hydroxocobalamin: synthesis of adenosylcobalamin by intact rat liver mitochondria. Archive of Biochemisty and Biophysics. 1978; 189: 441-447.
28. Masakoa T. High dose methotrexate therapy with citrovorum factor rescue for acute leukemia and malignant lymphoma, in Methotrexate in Cancer Therapy, eds. K. Kimura and Y.M. Wang, pp. 173-178, New York: Raven Press, 1986.